DelveInsight's "Post-Operative Cataract Surgery Inflammation Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Post-Operative Cataract Surgery Inflammation market size and shares analysis in the seven major markets (7MM). The report also covers emerging drugs, current treatment practices, Post-Operative Cataract Surgery Inflammation Market Shares of the individual therapies, a detailed current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.
The report analyses the Post-Operative Cataract Surgery Inflammation Market trends and developments in the seven major markets (i.e. the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.
Post-Operative Cataract Surgery Inflammation Disease Overview
Cataract surgery, also called lens replacement surgery, is the removal of the natural lens of the eye that has developed an opacification, which is referred to as a cataract, and its replacement with an intraocular lens. A cataract is the leading cause of blindness in the world, accounting for half of blindness and affecting about 20 million people. Although cataract surgery is an effective method for restoring vision, individuals in developing countries have limited access to cataract surgery services. In addition, cataract is also one of the major socio-economic and public health burdens, even in developed countries. This is because the volume of cataract surgery has increased due to an aging population and an increase in cataract surgery services.
Severe inflammation presenting in the immediate postoperative period (up to 96 h after surgery) will generally have one of four causes: acute postoperative endophthalmitis, toxic anterior segment syndrome (TASS), lens-induced uveitis, or reactivation of underlying uveitis disease.
Post-Operative Cataract Surgery Inflammation Market Key Facts
- Several estimates and population-based studies suggest that age-related cataract affects more than 22 million people in the United States and the numbers are expected to rise in the coming decades. Consequently, cataract surgery is the most common surgical procedure performed by ophthalmic surgeons in the US.
- Postoperative inflammation following cataract surgery is a typical occurrence but is usually easily managed and of limited clinical impact. It is usually divided into acute and chronic phases depending upon the duration of the impact [Taravati et al. (2012)].
- As per a case report study titled “Post-cataract Surgery Endophthalmitis Treated with Core Vitrectomy: A Case Report”, Postoperative endophthalmitis is one of the most serious complications after cataract surgery through its frequency may be low.
Post-Operative Cataract Surgery Inflammation Market Share
The Post-Operative Cataract Surgery Inflammation market is expected to increase during the forecast period owing to the increasing cases of cataract surgery and post-operative inflammation associated with the surgery and the approval of emerging therapies.
The Post-Operative Cataract Surgery Inflammation market analysis section of the report helps to understand the current and forecasted Post-Operative Cataract Surgery Inflammation Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers. The report gives complete detail of Post-Operative Cataract Surgery Inflammation Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Post-Operative Cataract Surgery Inflammation Epidemiology Forecast
The epidemiology section covers detailed insights about the patient pool for every seven major countries. It helps to recognize the causes of current and forecasted Post-Operative Cataract Surgery Inflammation Epidemiology Trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Post-Operative Cataract Surgery Inflammation Epidemiology Segmentation
- Number of Cases of Cataract
- Number of Cases undergoing Cataract Surgery
- Number of Cases of Post-Operative Cataract Surgery Inflammation
- Diagnosed and Treatable Cases of Post-Operative Cataract Surgery Inflammation
Some of the key companies in the Post-Operative Cataract Surgery Inflammation market include Oculis Pharma, Alcon Research, Formosa Pharmaceuticals, Eyepoint Pharmaceuticals, and many others. Post-Operative Cataract Surgery Inflammation Therapies covered in the report include OCS-01, APP13007, Nepafenac, Dexycu, and several others.
Report Assessment
- Unmet Needs
- Market Attractiveness
- Current Treatment Practices
- Post-Operative Cataract Surgery Inflammation Market Drivers
- Post-Operative Cataract Surgery Inflammation Market Barriers
- Post-Operative Cataract Surgery Inflammation Pipeline Product
For more details, visit: Post-Operative Cataract Surgery Inflammation Market Share